Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA) - Reetz, K; Hilgers, R D; Isfort, S (Neurol Res Pract, 2019)
et al.